PRI-724 is under investigation in clinical trial NCT03620474 (Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.